Health Care: Drugs

Redhill Biopharma Ltd (RDHL: NASDAQ)

$8.52 n/a | n/a%
02/05/16 - 03:59 PM ET
Company Cash Flow
Dec 2014 Dec 2013 Dec 2012
Cash Flow From Operating Activities
Net Income (Loss) -10.71M -10.63M -10.33M
Operating Gains/Losses 0.00 -54.00K -57.00K
Extraordinary Gains / Losses 0.00 0.00 0.00
(Increase) Decrease In Receivables 0.00 0.00 0.00
(Increase) Decrease in Inventories 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00
(Decrease) Increase In Payables -770.00K 1.34M 568.00K
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital 0.00 0.00 0.00
Other Non-Cash Items 1.81M 1.18M 1.63M
Net Cash From Continuing Operations -12.23M -8.44M -6.79M
Net Cash From Discontinued Operations 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -12.23M -8.44M -6.79M
Sale of Property, Plant & Equipment 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 243.00K 876.00K 1.59M
Purchases of Property, Plant & Equipment -1.10M -224.00K -108.00K
Acquisitions 0.00 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 -1.03M
Other Cash from Investing Activities -17.00M 477.00K 2.53M
Cash Provided by Financing Activities
Net Cash From Investing Activities -17.86M 1.13M 2.98M
Issuance of Debt 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 24.37M 2.28M 6.55M
Repayment of Long-Term Debt 0.00 0.00 0.00
Repurchase of Capital Stock 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00
Other Financing Charges, Net 0.00 0.00 0.00
Net Cash From Financing Activities 24.37M 2.28M 6.55M
Effect of Exchange Rate Changes -237.00K 64.00K 12.00K
Net Change in Cash & Cash Equivalents -5.96M -4.96M 2.74M

Portfolios with RDHL

  • Portfolio NameUser Type

Latest RDHL Headlines from TheStreet

More Financial News for RDHL

Press Releases for RDHL

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter